Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch

Journal of Crohn's and Colitis

Volumn 7, Issue 11, 2013, Pages

  Pavlidis, Polychronis ^a   Forbes, Alastair ^b   Bogdanos, Dimitrios P ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GP2 ANTIBODY; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BLOOD SAMPLING; COLON RESECTION; CROHN DISEASE; DISEASE DURATION; ENTERITIS; HUMAN; ILEITIS; ILEUM POUCH; INNATE IMMUNITY; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; ULCERATIVE COLITIS;

AUTOANTIBODIES; COLONIC POUCHES; FEMALE; GPI-LINKED PROTEINS; HUMANS; MALE; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE;

EID: 84884821417     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.06.010     Document Type: Letter

References (4)

1. Werner L., Sturm A., Roggenbuck D., Yahav L., Zion T., Meirowithz E., et al. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch. J Crohns Colitis 2013, 7:e522-e523. (this issue).
2. Pavlidis P., Romanidou O., Roggenbuck D., Mytilinaiou M.G., Al-Sulttan F., Liaskos C., et al. Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease. Clin Dev Immunol 2012, 2012:640835.
3. Pavlidis P., Forbes A., Bogdanos D.P. Antibodies to glycoprotein 2 (GP2) in patients with inflammatory bowel diseases from UK. Clin Chim Acta 2011, 412(11-12):1163-1164.
4. Werner L., Paclik D., Fritz C., Reinhold D., Roggenbuck D., Sturm A. Identification of pancreatic glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responses. J Immunol 2012, 189:2774-2783.